Breast cancer survival in the US and Europe: a CONCORD high-resolution study

被引：90

作者：

Allemani, Claudia ^{[1
,2
]}

Sant, Milena ^{[2
]}

Weir, Hannah K. ^{[3
]}

Richardson, Lisa C. ^{[3
]}

Baili, Paolo ^{[4
]}

Storm, Hans ^{[5
]}

Siesling, Sabine ^{[6
]}

Torrella-Ramos, Ana ^{[7
]}

Voogd, Adri C. ^{[8
]}

Aareleid, Tiiu ^{[9
]}

Ardanaz, Eva ^{[10
]}

Berrino, Franco ^{[11
]}

Bielska-Lasota, Magdalena ^{[12
]}

Bolick, Susan ^{[13
]}

Cirilli, Claudia ^{[14
]}

Colonna, Marc ^{[15
]}

Contiero, Paolo ^{[16
,17
]}

Cress, Rosemary ^{[18
]}

Crocetti, Emanuele ^{[19
]}

Fulton, John P. ^{[20
]}

Grosclaude, Pascale ^{[21
]}

Hakulinen, Timo ^{[22
]}

Isabel Izarzugaza, M. ^{[23
]}

Malmstrom, Per ^{[24
]}

Peignaux, Karin ^{[25
]}

Primic-Zakelj, Maja ^{[26
]}

Rachtan, Jadwiga ^{[27
]}

Diba, Chakameh Safaei ^{[28
]}

Sanchez, Maria-Jose ^{[29
,30
]}

Schymura, Maria J. ^{[31
]}

Shen, Tiefu ^{[32
]}

Traina, Adele ^{[33
]}

Tryggvadottir, Laufey ^{[34
,35
]}

Tumino, Rosario ^{[36
,37
]}

Velten, Michel

Vercelli, Marina

Wolf, Holly J.

Woronoff, Anne-Sophie

Wu, Xiaocheng

Coleman, Michel P. ^{[1
]}

机构：

[1] Univ London London Sch Hyg & Trop Med, Canc Res UK Canc Survival Grp, Dept Noncommunicable Dis Epidemiol, London WC1E 7HT, England

[2] Fdn IRCCS Ist Nazl Tumori, Analyt Epidemiol Unit, Dept Prevent & Predict Med, Milan, Italy

[3] Ctr Dis Control & Prevent, Div Canc Prevent & Control, Atlanta, GA USA

[4] Fdn IRCCS Ist Nazl Tumori, Descript Studies & Hlth Planning Unit, Milan, Italy

[5] Danish Canc Soc, Dept Canc Prevent & Documentat, Copenhagen O, Denmark

[6] Comprehens Canc Ctr Netherlands, Netherlands Canc Registry, NL-3501 DB Utrecht, Netherlands

[7] Comunitat Valenciana, Canc Registry Castellon, Castellon de La Plana, Spain

[8] Eindhoven Canc Registry, Dept Res, NL-5600 AE Eindhoven, Netherlands

[9] Natl Inst Hlth Dev, Dept Epidemiol & Biostat, Tallinn, Estonia

[10] CIBERESP, Navarra Canc Registry, Navarra Publ Hlth Inst, Navarra, Spain

[11] Fdn IRCCS Ist Nazl Tumori, Unit Etiol Epidemiol & Prevent, Dept Prevent & Predict Med, Milan, Italy

[12] Natl Inst Hyg, Bioeth & Hlth Psychol Unit, Dept Hlth Promot & Postgrad Educ, Natl Inst Publ Hlth, PL-00791 Warsaw, Poland

[13] S Carolina Cent Canc Registry, Columbia, SC USA

[14] Modena Canc Registry, Modena, Italy

[15] Isere Canc Registry, Meylan, France

[16] Fdn IRCSS Ist Nazl Tumori, Canc Registry, Milan, Italy

[17] Fdn IRCSS Ist Nazl Tumori, Environm Epidemiol Unit, Milan, Italy

[18] Calif Canc Registry, Inst Publ Hlth, Sacramento, CA USA

[19] ISPO, Tuscany Canc Registry, UO Epidemiol Clin & Descrittiva, Florence, Italy

[20] Rhode Isl Canc Registry, Providence, RI USA

[21] Tarn Canc Registry, Albi, France

[22] Finnish Canc Registry, Inst Stat & Epidemiol Canc Res, FIN-00170 Helsinki, Finland

[23] Registros & Informac Sanitaria, Dpto Sanidad Gobierno Vasco, C Donostia San Sebastian, Vitoria Gasteiz, Spain

[24] Skane Univ Hosp, Skane Dept Oncol, Lund, Sweden

[25] Ctr Georges Francois Leclerc, Cote dOr Breast & Gynecol Canc Registry, Dijon, France

[26] Inst Oncol Ljubljana, Epidemiol & Canc Registry, Ljubljana, Slovenia

[27] M Skodowska Curie Mem Inst, Cracow Canc Registry, Ctr Oncol, Krakow, Poland

[28] Natl Hlth Informat Ctr, Natl Canc Registry Slovakia, Bratislava, Slovakia

[29] Andalusian Sch Publ Hlth, Granada, Spain

[30] CIBER Epidemiol & Salud Publ, Madrid, Spain

[31] New York State Canc Registry, Menands, NY USA

[32] Illinois State Canc Registry, Springfield, IL USA

[33] ARNAS Civ, POM Ascoli, Dept Oncol, Palermo, Italy

[34] Univ Iceland, Fac Med, Reykjavik, Iceland

[35] Iceland Canc Registry, IS-125 Reykjavik, Iceland

[36] Civile MP Arezzo Hosp, Canc Registry, ASP Ragusa, Ragusa, Italy

[37] Civile MP Arezzo Hosp, Histopathol Unit, ASP Ragusa, Ragusa, Italy

来源：

INTERNATIONAL JOURNAL OF CANCER | 2013年 / 132卷 / 05期

关键词：

CONCORD; net survival; excess hazard; cancer registries; FLEXIBLE PARAMETRIC MODELS; RELATIVE SURVIVAL; UNITED-STATES; POPULATION; THERAPY; STAGE; CARCINOMA; WOMEN;

D O I：

10.1002/ijc.27725

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Breast cancer survival is reportedly higher in the US than in Europe. The first worldwide study (CONCORD) found wide international differences in age-standardized survival. The aim of this study is to explain these survival differences. Population-based data on stage at diagnosis, diagnostic procedures, treatment and follow-up were collected for about 20,000 women diagnosed with breast cancer aged 15-99 years during 1996-98 in 7 US states and 12 European countries. Age-standardized net survival and the excess hazard of death up to 5 years after diagnosis were estimated by jurisdiction (registry, country, European region), age and stage with flexible parametric models. Breast cancers were generally less advanced in the US than in Europe. Stage also varied less between US states than between European jurisdictions. Early, node-negative tumors were more frequent in the US (39%) than in Europe (32%), while locally advanced tumors were twice as frequent in Europe (8%), and metastatic tumors of similar frequency (5-6%). Net survival in Northern, Western and Southern Europe (81-84%) was similar to that in the US (84%), but lower in Eastern Europe (69%). For the first 3 years after diagnosis the mean excess hazard was higher in Eastern Europe than elsewhere: the difference was most marked for women aged 70-99 years, and mainly confined to women with locally advanced or metastatic tumors. Differences in breast cancer survival between Europe and the US in the late 1990s were mainly explained by lower survival in Eastern Europe, where low healthcare expenditure may have constrained the quality of treatment.

引用

页码：1170 / 1181

页数：12

共 33 条

[1]

ABE O, 1992, LANCET, V339, P71

[2]

Abe O, 1998, LANCET, V352, P930

[3] NEW LOOK AT STATISTICAL-MODEL IDENTIFICATION [J].

AKAIKE, H .

IEEE TRANSACTIONS ON AUTOMATIC CONTROL, 1974, AC19 (06) :716-723

[4] Variation in 'standard care' for breast cancer across Europe: A EUROCARE-3 high resolution study [J].

Allemani, Claudia ;

Storm, Hans ;

Voogd, Adri C. ;

Holli, Kaija ;

Izarzugaza, Isabel ;

Torrella-Ramos, Ana ;

Bielska-Lasota, Magdalena ;

Aareleid, Tiiu ;

Ardanaz, Eva ;

Colonna, Marc ;

Crocetti, Emanuele ;

Danzon, Arlette ;

Federico, Massimo ;

Garau, Isabel ;

Grosclaude, Pascale ;

Hedelin, Guy ;

Martinez-Garcia, Carmen ;

Peignaux, Karin ;

Plesko, Ivan ;

Primic-Zakelj, Maja ;

Rachtan, Jadwiga ;

Tagliabue, Giovanna ;

Tumino, Rosario ;

Traina, Adele ;

Tryggvadottir, Laufey ;

Vercelli, Marina ;

Sant, Milena .

EUROPEAN JOURNAL OF CANCER, 2010, 46 (09) :1528-1536

[5]

Alley LG, 2007, J REGISTRY MANAG, V34, P148

[6]

[Anonymous], 1997, Oncology (Williston Park), V11, P199

[7]

[Anonymous], 1985, JAMA, V254, P3461

[8]

[Anonymous], NCI MONOGRAPH

[9]

[Anonymous], 1992, Lancet, V339, P1

[10]

Baili P, 2008, TUMORI J, V94, P658

← 1 2 3 4 →